Form 8-K ALDER BIOPHARMACEUTICALS For: May 07
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Alder BioPharmaceuticals (ALDR) Misses Q1 EPS by 1c
May 7, 2015 4:30 PM EDTAlder BioPharmaceuticals (NASDAQ: ALDR) reported Q1 EPS of ($0.40), $0.01 worse than the analyst estimate of ($0.39).
For earnings history and earnings-related data on Alder BioPharmaceuticals (ALDR) click here.
... More


